Two decades after a small Duke breast cancer vaccine trial, every participant is still alive — a rare outcome for metastatic disease. When researchers looked closer, they found the women’s immune systems still carried “memory” cells that recognised the cancer. Science Daily https://www.sciencedaily.com/releases/2026/01/260128075345.htm
#ShareGoodNewsToo
Embed Notice
HTML Code
Corresponding Notice
- Embed this notice
Ada Palmer (adapalmer@wandering.shop)'s status on Tuesday, 17-Feb-2026 04:16:12 JST
Ada Palmer